Ownership history in Affinity Asset Advisors, LLC · 5 quarters on record
This page tracks every 13F SEC filing in which Affinity Asset Advisors, LLC reported a position in PROQR THRAPEUTICS N V (PRQR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 2,454,278 | -1,145,722 | -31.8% | 0.28% | $5.0M | $2.02 |
| 2025 Q3 | ADDED | 3,600,000 | +100,488 | +2.9% | 0.67% | $7.7M | $2.13 |
| 2025 Q2 | ADDED | 3,499,512 | +215,000 | +6.5% | 0.98% | $7.1M | $2.04 |
| 2025 Q1 | ADDED | 3,284,512 | +459,512 | +16.3% | 0.42% | $4.4M | $1.33 |
| 2024 Q4 | INITIATED | 2,825,000 | — | — | 1.00% | $7.5M | $2.65 |
As of 2025 Q4 — sorted by position size